Pilulka stock traded at CZK 900 per share at the end 2024 translating into a market capitalization of USD 40.1 mil.
Since the end of 2019, stock has appreciated by 0% representing an annual average growth of 0%. In absolute terms, the value of the company rose by USD 0 mil.
At the end of 2024, the firm traded at price to earnings of 11.5x. Over the last five years, this multiple achieved a high of 91.1x in 2022 and a low of -73.4x in 2021 with an average of 6.56x.
In terms of EV/EBITDA, stock traded at 5.56x at the end of 2024. Since 2019, stock has traded between -71.9x and 47.2x with an average of 1.52x.